CrushSCI.com
提供学术论文选刊润色服务
CANCER IMMUNOLOGY IMMUNOTHERAPY 期刊封面 医学
返回期刊列表

Review Cycle Records

CANCER IMMUNOLOGY IMMUNOTHERAPY

Springer SCIE OA
2026新锐 2区2025中科院 3区2025 JCR Q1
75.7平均天数
46中位天数
34最短天数
144最长天数
3742025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

34 天

Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis

作者K. E. Blethen; C. P. Wolford; G. L. Pecar; T. A. Arsiwala; E. Adjeroh; L. P. Dykstra; B. N. Kielkowski; P. R. Lockman

作者单位1. Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, USA; 2. Rockefeller Neuroscience Institute, West Virginia University, Morgantown, USA

PDF源文件 DOI 网页
134 天

Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma

作者Feihua Chen; Mouchun Gong; Dengcheng Weng; Zhaoqing Jin; Guofeng Han; Ziqiang Yang; Junjun Han; Jianjiang Wang

作者单位1. Department of General Surgery, Hangzhou Medical College Affiliated Lin’an People’s Hospital, Hangzhou, China

PDF源文件 DOI 网页
34 天

Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment

作者Joanna Baginska; Allison Nau; Ilana Gomez Diaz; Anita Giobbie-Hurder; Jason Weirather; Juliana Vergara; Charlotte Abrecht; Margaret Hallisey; Jenna Dennis; Mariano Severgnini; Julia Huezo; Isabella Marciello; Osama Rahma; Michael Manos; Andrew S. Brohl; Philippe L. Bedard; Daniel J. Renouf; Elad Sharon; Howard Streicher; Patrick A. Ott; Elizabeth I. Buchbinder; F. Stephen Hodi

作者单位1. Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, USA; 2. Department of Data Science, Dana-Farber Cancer Institute, Boston, USA; 3. Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA; 4. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 5. Cancer and Department of Medicine, University of British Columbia, Vancouver, Canada; 6. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA

PDF源文件 DOI 网页
35 天

Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice

作者Akashdip Singh; Eline T. A. M. Mommers-Elshof; Saskia V. Vijver; J. H. Marco Jansen; Susanne Gonder; Robert Jan Lebbink; Dominique Bihan; Richard W. Farndale; Louis Boon; Solomon Langermann; Jeanette H. W. Leusen; Dallas Flies; Linde Meyaard; M. Ines Pascoal Ramos

作者单位1. Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands; 2. Oncode Institute, Utrecht, The Netherlands; 3. Department of Biochemistry, University of Cambridge, Cambridge, UK; 4. JJP Biologics, Warsaw, Poland; 5. Nextcure, Beltsville, USA

PDF源文件 DOI 网页
39 天

Vaccination against neoantigens induced in cross-priming cDC1 in vivo

作者Emily S. Clark; Ana Paula Benaduce; Wasif N. Khan; Olivier Martinez; Eli Gilboa

作者单位1. Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, USA; 2. Department of Biological Sciences, Florida International University, Miami, USA; 3. Mnemo Therapeutics, Paris, France; 4. Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, USA

PDF源文件 DOI 网页
45 天

Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases

作者Celine Man Ying Li; Yoko Tomita; Bimala Dhakal; Teresa Tin; Runhao Li; Josephine A. Wright; Laura Vrbanac; Susan L. Woods; Paul Drew; Timothy Price; Eric Smith; Guy J. Maddern; Kevin Fenix

作者单位1. Discipline of Surgery, Adelaide Medical School, The University of Adelaide, Adelaide, Australia; 2. The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia; 3. Medical Oncology, The Queen Elizabeth Hospital, The University of Adelaide, Adelaide, Australia; 4. Precision Medicine, South Australian Health and Medical Research Institute, Adelaide, Australia; 5. Department of Medical Specialties, Adelaide Medical School, The University of Adelaide, Adelaide, Australia

PDF源文件 DOI 网页
46 天

Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53

作者Brendan L. C. Kinney; Sreenivasulu Gunti; Vikash Kansal; Connor J. Parrish; Nabil F. Saba; Yong Teng; Mary Katherine Henry; Fang-Yi Su; Gabriel A. Kwong; Nicole C. Schmitt

作者单位1. Department of Otolaryngology – Head and Neck Surgery, Head and Neck Cancer Program, Winship Cancer Institute, Emory University School of Medicine, Atlanta, USA; 2. Winship Cancer Institute, Emory University, Atlanta, USA; 3. National Institute of Deafness and Communication Disorders, NIH, Bethesda, USA; 4. Saint Louis University School of Medicine, St. Louis, USA; 5. Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, USA; 6. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory School of Medicine, Atlanta, USA; 7. Emory University School of Medicine, Atlanta, USA

PDF源文件 DOI 网页
108 天

Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies

作者Xinfeng Chen; Binghe Tan; Haizhou Xing; Xuan Zhao; Yu Ping; Zhen Zhang; Jianmin Huang; Xiujuan Shi; Na Zhang; Boxu Lin; Weijie Cao; Xin Li; Xudong Zhang; Ling Li; Zhongxing Jiang; Mingzhi Zhang; Wei Li; Mingyao Liu; Bing Du; Yi Zhang

作者单位1. Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China; 4. BRL Medicine Inc, Shanghai, China; 5. Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 6. State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou, China; 7. School of Life Sciences, Zhengzhou University, Zhengzhou, China; 8. Engineering Key Laboratory for Cell Therapy of Henan Province, Zhengzhou, China

PDF源文件 DOI 网页
132 天

Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells

作者Libao Liu; Laurie Rangan; Nathan Vanalken; Qianqian Kong; Susan Schlenner; Steven De Jonghe; Dominique Schols; Tom Van Loy

作者单位1. Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium; 2. Laboratory of Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

PDF源文件 DOI 网页
82 天

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

作者M Costa-Garcia; JJ Rojas; MD Ramos; P Barlabé; P Calvo; J Navas; R Alemany; R Moreno

作者单位1. Cancer Immunotherapy Group, Oncobell and iProCURE programs, IDIBELL-Institut Català d’Oncologia, l’Hospitalet de Llobregat, Barcelona, Spain; 2. Immunology Unit, Department of Pathology and Experimental Therapies, School of Medicine, University of Barcelona-UB, Barcelona, Spain; 3. Immunity, Inflammation, and Cancer Group, Oncobell program, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, l’Hospitalet de Llobregat, Barcelona, Spain; 4. Program of Regenerative Medicine, Centre for Applied Medical Research (CIMA), University of Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Pamplona, Spain

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。